Vor Biopharma VOR Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
Based on the most recent quarter.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's cash ratio?
- Vor Biopharma (VOR) reported cash ratio of 10.6× in Q1 2026.
- How has Vor Biopharma's cash ratio changed year-over-year?
- Vor Biopharma's cash ratio increased by 253.1% year-over-year, from 3× to 10.6×.
- What is the long-term trend for Vor Biopharma's cash ratio?
- Over 5 years (2020 to 2025), Vor Biopharma's cash ratio has grown at a 27.1% compound annual growth rate (CAGR), from 4.8× to 15.8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.